John Wiley & Sons (WLY) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

John Wiley & Sons

NYSE•Communication Services•Publishing

$49.54+0.21(<0.01%)Pre-market

Market Cap

$2.44B

P/E

12.3x

P/S

1.5x

P/B

3.1x

John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Kingdom, Germany, and internationally. It operates through Research and Learning segment. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company's Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.

How this company scores

WeakMetricSide Score: 56/100

Grade capped at D — Interest coverage below 1× (0.2x) — earnings cannot cover interest. Strongest: Profitability (20/25); weakest: Balance Sheet & Red Flags (6/25).

Profitability20/25

Growth13/25

Balance Sheet & Red Flags6/25

Cash & Earnings Quality17/25

Strengths

Rising free cash flowHigh ROERising earningsProfit converts from growth

Grade capped at D

Interest coverage below 1× (0.2x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 12.3x5y range 9.4x – 123.9x

Currently below its 13-quarter median.

P/S · 1.5x5y range 0.8x – 1.5x

Currently near its 20-quarter median.

P/B · 3.1x5y range 1.9x – 3.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Red Flag

Free cash flow has been negative in 4 of the last 8 quarters — earnings are not translating to cash.

Leverage Risk

Watch

Debt-to-equity has risen 43.6% recently — increasing financial risk even if the current ratio is manageable.

Price & Volume

Market Cap $2.44B

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.67B
Q. Revenue: $386.36M
TTM EBITDA: $393.19M
TTM Op. Income: $248.83M
Q. Op. Income: $2.94M
TTM Net Income: $198.19M
Q. Net Income: $-11.73M
EPS: $-0.23
Shares Out.: $50.75M

$1.67B in TTM revenue declined 0.3% YoY, reaching $386.36M last quarter. TTM EBITDA of $393.19M and TTM operating income of $248.83M show growth is flowing through to the bottom line. TTM net income of $198.19M means revenue is converting into profit. Over the past year, TTM revenue is down 0% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 10.4%
Op. Margin: 0.8%
Net Margin: -3.0%

Op. margin of 0.8% is down 7.0% YoY — costs are rising relative to revenue. Net margin at -3.0% Over the past year, operating margin is down 90% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 12.3x
P/S Ratio: 1.5x
P/B Ratio: 3.1x

At 12.3x P/E, the stock trades below typical market levels. P/S of 1.5x and P/B of 3.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 43% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.13B
Cash: $106.43M
Long-Term Debt: $1.28B
Book Value: $797.04M
D/E Ratio: 1.6
Debt/EBITDA: 31.7

With $3.13B in assets and $1.28B in long-term debt, D/E is 1.6and book value is $797.04M — moderate leverage. Over the past year, debt/equity is up 44% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-55.27M
TTM Free Cash Flow: $239.89M
FCF Margin: 14.4%
FCF / Net Income: 1.2

TTM FCF of $239.89M on $-55.27M in operating cash flow. The FCF / Net Income ratio of 1.2x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 5 consecutive quarters — an improving trend.